Skip to main content
Figure 3 | Journal of Hematology & Oncology

Figure 3

From: Molecular mechanism of the schedule-dependent synergistic interaction in EGFR-mutant non-small cell lung cancer cell lines treated with paclitaxel and gefitinib

Figure 3

Synergism of sequence-dependent cytotoxicity between paclitaxel and gefitinib. Points, mean values of three different experiments. ○ T → G, paclitaxel followed by gefitinib. □ G → T, gefitinib followed by paclitaxel. △ T + G, concomitant paclitaxel and gefitinib. The sequence T → G produced the most potent cytotoxic growth inhibition. The T → G sequence resulted in a synergistic effect.

Back to article page